La Rabta Hospital Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00430625
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

La rabta hospital | La Rabta Maternity Hospital

Active Ingredients

Drugs in Phase 4 Trials (2)

mifepristone (mifeprex) (1 trial)

misoprostol (cytotec) (1 trial)

Drugs in Phase 3 Trials (1)

imiglucerase (cerezyme) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gaucher Disease (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3